Centene Corporation (CNC) fundamentals: P/E, valuation, undervalued?
Centene Corporation · Health Care · ref. ETF XLV · price $65.33
In short — Centene Corporation trades at —× earnings (P/E), 12.3× forward, with a net margin of -2.8 % and revenue growth of +5 %. Read: Not (yet) profitable (valued on growth, not earnings).
Is Centene Corporation stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$65.33+130.2% over range
Aug 28, 25low $28.38 · high $68.72Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
47% recommend buying · 17 analysts
Valuation : Not (yet) profitable — valued on growth, not earnings
Valuation
—
P/E (price/earnings)
12.3
Forward P/E
—
PEG
1.4
Price/book (P/B)
$32.3B
Market cap
-10.34
EPS
Profitability & growth
-2.8 %
Net margin
+5 %
Revenue growth
—
Earnings growth
$16.1B
Total debt
Centene Corporation income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $144.5B | $1.2B | 0.8 % |
| 2023 | $154.0B | $2.7B | 1.8 % |
| 2024 | $163.1B | $3.3B | 2.0 % |
| 2025 | $194.8B | $-6.7B | -3.4 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Centene Corporation's P/E and is the stock undervalued? What's a good P/E?
Centene Corporation's P/E is — (forward 12.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Not (yet) profitable".
Is Centene Corporation profitable?
Centene Corporation has a net margin of -2.8 % (EPS -10.34). The company is not (yet) profitable.
Is CNC stock expensive?
Our read: "Not (yet) profitable" — valued on growth, not earnings. Cross-check with growth and sector.
💬 A question about Centene Corporation? The JPI assistant answers using our backtest data.
Keep exploring Centene Corporation